Blood vessels on the retina

A Therapy For Wet AMD And Other Conditions Where There Is Abnormal Blood Vessel Growth

Researchers at Moorfields Eye Hospital and UCL Institute of Ophthalmology have discovered a new molecule called leucine-rich alpha-2-glycoprotein 1 (LRG1) which could hold the key for future therapy of a number of conditions where there is abnormal blood vessel growth, including age-related macular degeneration (AMD), rheumatoid arthritis, proliferative diabetic retinopathy, atherosclerosis and cancer. The research team has now received £5.6 million funding from the Medical Research Council (MRC) to conduct early phase clinical trials.